Hypertension in diabetes

Australian Prescriber

Volumn 25, Issue 1, 2002, Pages 8-10

  Lowe, Julia ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

ACE inhibitors; Calcium antagonists; Cardiovascular; Complications

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ETHNIC GROUP; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; SHORT SURVEY;

EID: 0036172511     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2002.005     Document Type: Short Survey

References (10)

1. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
2. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
3. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
4. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
5. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
6. High blood pressure and diabetes mellitus: Are all hypertensive drugs created equal?
7. Treatment of hypertensive patients with diabetes
8. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
9. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials
10. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy